SOHO 2023 Data From the Phase 3 COMMANDS Study: Luspatercept vs. Epoetin Alfa for Treatment of Anemia in Patients With ESA‑Naïve LR-MDS Requiring Red Blood Cell Transfusions

92 views
October 18, 2023
0 Comments
Login to view comments. Click here to Login